• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY Back to Search Results
Model Number ANTI-TSHR
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/23/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).- (b)(6).
 
Event Description
The initial reporter stated they received discrepant thyroid results for three samples from the same patient tested on a cobas 8000 e 602 module.The first sample (dated (b)(6) 2019) had discrepant results for the elecsys tsh assay, elecsys ft3 iii, and the elecsys ft4 iii assay.The incorrect results from this sample were reported outside of the laboratory to the patient.This sample was repeated on a siemens analyzer.The second sample (dated (b)(6) 2019) had discrepant ft3 and ft4 results.No incorrect results from this sample were reported outside of the laboratory.This sample was repeated on an ortho vitros analyzer.The third sample (dated (b)(6) 2019) had discrepant results for the elecsys anti-tshr immunoassay.It was asked, but it is not known if any incorrect results from this sample were reported outside of the laboratory.This sample was repeated on an ortho vitros analyzer.This medwatch will apply to the anti-tshr assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the tsh assay, refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay, and refer to the medwatch with patient identifier (b)(6) for information related to the ft4 assay.Refer to all patient data.The serial number of the reporter's e 602 analyzer is (b)(4).
 
Manufacturer Narrative
It has been clarified that no incorrect results were reported outside of the laboratory for the third sample dated (b)(6) 2019.
 
Manufacturer Narrative
Medwatch field model #, serial #, expiration date, catalog #, lot #, other #, udi # has been updated.
 
Manufacturer Narrative
Upon further investigation of the patient sample, the values measured at the customer site could be reproduced.It was determined that the sample contains an interfering factor against the streptavidin component of the anti-tshr assay.Per product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR
Type of Device
ANTI-TSHR IMMUNOASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9178514
MDR Text Key217308371
Report Number1823260-2019-03656
Device Sequence Number1
Product Code JZO
Combination Product (y/n)N
PMA/PMN Number
K080092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup,Followup
Report Date 03/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberANTI-TSHR
Device Catalogue Number08496609190
Device Lot Number406920
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 09/24/2019
Initial Date FDA Received10/11/2019
Supplement Dates Manufacturer Received09/24/2019
09/24/2019
09/24/2019
Supplement Dates FDA Received10/11/2019
11/21/2019
03/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TOPAZOLE.
-
-